Solid Biosciences (SLDB) Other financing activities (2018 - 2026)

Solid Biosciences (SLDB) has 6 years of Other financing activities data on file, last reported at $18000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $18000.0; the trailing twelve-month figure through Mar 2026 stood at $24000.0 (down 92.16% YoY), and the FY2025 full-year result was $6000.0, down 98.69% from the prior year.
• Other financing activities improved to $18000.0 in Q1 2026, from $6000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $278000.0 in Q3 2024 to a low of $6000.0 in Q2 2025.
• A 4-year average of $71857.1 and a median of $19000.0 in 2024 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities fell 24.14% in 2022 and slumped 33.33% in 2025, its largest moves.
• Tracing SLDB's Other financing activities over 4 years: stood at $22000.0 in 2022, then declined by 13.64% to $19000.0 in 2024, then plunged by 68.42% to $6000.0 in 2025, then surged by 200.0% to $18000.0 in 2026.
• Business Quant data shows SLDB's Other financing activities at $18000.0 in Q1 2026, $6000.0 in Q2 2025, and $19000.0 in Q4 2024.